» Authors » Andrea Orsey

Andrea Orsey

Explore the profile of Andrea Orsey including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 142
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Phillips C, Kennelly R, Carroll C, Gibson F, Elgarten C, Orsey A, et al.
Support Care Cancer . 2024 Sep; 32(10):644. PMID: 39243282
Purpose: Malnutrition is common in children with cancer. While multiple validated malnutrition screens exist, there is no universal, standardized approach to screen or diagnose malnutrition. The Multinational Association of Supportive...
2.
Schechter T, Tardif-Theriault C, Culos-Reed N, Lewis V, Orsey A, Diorio C, et al.
BMJ Support Palliat Care . 2023 Dec; 15(2):204-212. PMID: 38160047
Objectives: The primary objective was to determine if individualised yoga for hospitalised children receiving intensive chemotherapy was associated with less fatigue using the Pediatric Quality of Life Inventory Multidimensional Fatigue...
3.
Tal A, Bailey K, Chou A, Offer K, Rosenblum J, Moerdler S, et al.
Pediatr Blood Cancer . 2022 Dec; 70(3):e30118. PMID: 36573297
Background: A recent survey of pediatric hematology oncology (PHO) physicians identified that a majority believe fellows are struggling to find jobs that align with their goals. Career development for trainees...
4.
Patel P, Robinson P, Cohen M, Devine K, Gibson P, Holdsworth M, et al.
Pediatr Blood Cancer . 2022 Oct; 69(12):e30001. PMID: 36221901
This clinical practice guideline provides recommendations for preventing acute and delayed phase chemotherapy-induced nausea and vomiting (CINV) in pediatric patients. The recommendations are based on two systematic reviews of randomized...
5.
Patel P, Robinson P, Wahib N, Cheung P, Wong T, Cabral S, et al.
Support Care Cancer . 2022 Aug; 30(11):8855-8869. PMID: 35953731
Purpose: To identify effective and safe interventions to prevent acute phase chemotherapy-induced nausea and vomiting (CINV) in adult and pediatric patients. Methods: We conducted a systematic review of randomized trials...
6.
Toro-Salazar O, Gillan E, Ferranti J, Orsey A, Rubin K, Upadhyay S, et al.
Cardiooncology . 2021 Feb; 1(1):1. PMID: 33530141
Background: Subacute cardiotoxicity, consisting of acute myocyte damage and associated left ventricular dysfunction, occurs early during anthracycline therapy. We investigated the impact of myocardial dysfunction, defined herein by a shortening...
7.
Tomlinson D, Baggott C, Dix D, Gibson P, Hyslop S, Johnston D, et al.
Support Care Cancer . 2018 Nov; 27(7):2665-2671. PMID: 30478671
Background: Objectives were to describe bothersome fatigue in children with cancer and hematopoietic stem cell (HSCT) recipients and to identify factors associated with severely bothersome fatigue. Methods: We included children...
8.
Hyslop S, Dupuis L, Baggott C, Dix D, Gibson P, Kuczynski S, et al.
J Pain Symptom Manage . 2018 Apr; 56(1):107-112. PMID: 29630923
Objectives: Primary objectives were to evaluate the interrater reliability and validity of proxy-report Symptom Screening in Pediatrics Tool (SSPedi) in children with cancer and pediatric hematopoietic stem cell transplant (HSCT)...
9.
Johnston D, Hyslop S, Tomlinson D, Baggott C, Gibson P, Orsey A, et al.
Cancer Med . 2018 Mar; 7(5):1750-1755. PMID: 29573197
Objectives were to describe any bothersome symptom and severely bothersome symptoms in inpatient children with cancer and hematopoietic stem cell transplant (HSCT) recipients. We included children 8-18 years of age...
10.
Dupuis L, Johnston D, Baggott C, Hyslop S, Tomlinson D, Gibson P, et al.
J Natl Cancer Inst . 2017 Dec; 110(6):661-668. PMID: 29272441
Background: The objective was to evaluate the reliability and validity of the self-report Symptom Screening in Pediatrics Tool (SSPedi) from the perspective of children with cancer and pediatric hematopoietic stem...